Barclays’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
109,743
+66,928
| +156% | +$1.37M | ﹤0.01% | 2151 |
|
|
2025
Q1 | $857K | Sell |
42,815
-6,198
| -13% | -$124K | ﹤0.01% | 2532 |
|
|
2024
Q4 | $1.31M | Sell |
49,013
-3,288
| -6% | -$87.6K | ﹤0.01% | 2472 |
|
|
2024
Q3 | $1.49M | Buy |
52,301
+39,567
| +311% | +$1.13M | ﹤0.01% | 2386 |
|
|
2024
Q2 | $277K | Sell |
12,734
-34,691
| -73% | -$755K | ﹤0.01% | 2866 |
|
|
2024
Q1 | $1.05M | Buy |
47,425
+8,045
| +20% | +$178K | ﹤0.01% | 2369 |
|
|
2023
Q4 | $850K | Buy |
39,380
+30,398
| +338% | +$656K | ﹤0.01% | 2715 |
|
|
2023
Q3 | $151K | Sell |
8,982
-528
| -6% | -$8.88K | ﹤0.01% | 3147 |
|
|
2023
Q2 | $131K | Sell |
9,510
-2,944
| -24% | -$40.6K | ﹤0.01% | 3289 |
|
|
2023
Q1 | $282K | Buy |
12,454
+5,866
| +89% | +$133K | ﹤0.01% | 2972 |
|
|
2022
Q4 | $155K | Sell |
6,588
-18,646
| -74% | -$439K | ﹤0.01% | 3230 |
|
|
2022
Q3 | $658K | Buy |
25,234
+24,040
| +2,013% | +$627K | ﹤0.01% | 2406 |
|
|
2022
Q2 | $26K | Sell |
1,194
-2,359
| -66% | -$51.4K | ﹤0.01% | 3984 |
|
|
2022
Q1 | $159K | Buy |
+3,553
| New | +$159K | ﹤0.01% | 3446 |
|